Zobrazeno 1 - 10
of 57
pro vyhledávání: '"F, Brichory"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N. Wiedemann, S. Rigotti, F. Brichory, C. Schusterbauer, D. Rechavi-Robinson, Gregoire Vuagniaux
Publikováno v:
European Journal of Cancer. 69:S134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::763e5ab2c8be02e78a482b68d9a8ae6c
https://doi.org/10.1016/s0959-8049(16)32997-5
https://doi.org/10.1016/s0959-8049(16)32997-5
Publikováno v:
British Journal of Cancer
The efficacy of radioimmunotherapy of tumours with radiolabelled monoclonal antibodies (MAbs) depends on the amount of antibody taken up by the tumour and on its intratumoral distribution. In the case of MAbs directed against intracellular antigens,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4734fda2cc4363c9889c772169a0d67
http://europepmc.org/articles/PMC2033938
http://europepmc.org/articles/PMC2033938
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J M, Oh, F, Brichory, E, Puravs, R, Kuick, C, Wood, J M, Rouillard, J, Tra, S, Kardia, D, Beer, S, Hanash
Publikováno v:
Proteomics. 1(10)
We have developed a comprehensive approach to identifying molecular changes in lung cancer that includes both genomic and proteomic analyses. The related effort has produced a large amount of data pertaining to gene expression at the RNA and protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e2be53b7048541517397cead34fd6ab2
https://pubmed.ncbi.nlm.nih.gov/11721642
https://pubmed.ncbi.nlm.nih.gov/11721642
Publikováno v:
Cancer research. 61(21)
We used a proteomic approach to identify proteins that commonly induce an antibody response in lung cancer. Sera from 64 newly diagnosed patients with lung cancer, 99 patients with other types of cancer, and 71 noncancer controls were analyzed for an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f6abbb45363f43d03eac102d4839dc70
https://pubmed.ncbi.nlm.nih.gov/11691811
https://pubmed.ncbi.nlm.nih.gov/11691811
Publikováno v:
Anticancer research. 21(2A)
Galectins are animal lectins, which may play a role in neoplastic transformation. Po66-Carbohydrate Binding Protein (Po66-CBP) belongs to the galectin-8 family and is expressed in lung tumor cells but not in normal ones. Recent studies showed that ga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1c99d8474b33210775bbe9aa345e4704
https://pubmed.ncbi.nlm.nih.gov/11396139
https://pubmed.ncbi.nlm.nih.gov/11396139
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Bulletin du cancer. 87(10)
Galectins are proteins structurally related to the lectin family. They share, with lectins, the ability to bind carbohydrate residues. Galectins are suspected to mediate several biological functions such as embryonic development growth, immune respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2b101aeb779d39a553bcd5af973e900
https://pubmed.ncbi.nlm.nih.gov/11084533
https://pubmed.ncbi.nlm.nih.gov/11084533
Publikováno v:
Anticancer research. 19(6B)
A monoclonal antibody, Po66, recognized an antigen named Po66 carbohydrate binding protein (PO66-CBP), which was homologous to the galectin-8 protein. Two additional isoforms previously not described were characterized. The aim of this study was to c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::034a8899ed53947b50886326df38ebc1
https://pubmed.ncbi.nlm.nih.gov/10697573
https://pubmed.ncbi.nlm.nih.gov/10697573